Annual Retained Earnings
-$660.82 M
-$23.66 M-3.71%
31 December 2023
Summary:
CASI Pharmaceuticals annual retained earnings is currently -$660.82 million, with the most recent change of -$23.66 million (-3.71%) on 31 December 2023. During the last 3 years, it has fallen by -$55.17 million (-9.11%). CASI annual retained earnings is now -2511.92% below its all-time high of -$25.30 million, reached on 31 December 1996.CASI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$685.71 M
-$8.39 M-1.24%
01 September 2024
Summary:
CASI Pharmaceuticals quarterly retained earnings is currently -$685.71 million, with the most recent change of -$8.39 million (-1.24%) on 01 September 2024. Over the past year, it has dropped by -$24.89 million (-3.77%). CASI quarterly retained earnings is now -2988.76% below its all-time high of -$22.20 million, reached on 31 March 1996.CASI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -3.8% |
| 3 y3 years | -9.1% | -13.2% |
| 5 y5 years | -26.1% | -30.9% |
CASI Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.1% | at low | -13.2% | at low |
| 5 y | 5 years | -26.1% | at low | -30.9% | at low |
| alltime | all time | -2511.9% | at low | -2988.8% | at low |
CASI Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$685.71 M(+1.2%) |
| June 2024 | - | -$677.31 M(+1.0%) |
| Mar 2024 | - | -$670.35 M(+1.4%) |
| Dec 2023 | -$660.82 M(+3.7%) | -$660.82 M(+0.8%) |
| Sept 2023 | - | -$655.67 M(+0.6%) |
| June 2023 | - | -$651.80 M(+1.5%) |
| Mar 2023 | - | -$642.32 M(+0.8%) |
| Dec 2022 | -$637.16 M(+5.2%) | -$637.16 M(+2.0%) |
| Sept 2022 | - | -$624.86 M(+0.7%) |
| June 2022 | - | -$620.57 M(+1.1%) |
| Mar 2022 | - | -$613.63 M(+1.3%) |
| Dec 2021 | -$605.64 M(+6.2%) | -$605.64 M(+0.9%) |
| Sept 2021 | - | -$599.97 M(+1.6%) |
| June 2021 | - | -$590.26 M(+1.1%) |
| Mar 2021 | - | -$583.84 M(+2.3%) |
| Dec 2020 | -$570.50 M(+8.9%) | -$570.50 M(+2.5%) |
| Sept 2020 | - | -$556.81 M(+3.0%) |
| June 2020 | - | -$540.36 M(+1.6%) |
| Mar 2020 | - | -$532.03 M(+1.6%) |
| Dec 2019 | -$523.91 M(+9.4%) | -$523.91 M(+2.3%) |
| Sept 2019 | - | -$512.07 M(+1.9%) |
| June 2019 | - | -$502.43 M(+3.1%) |
| Mar 2019 | - | -$487.11 M(+1.7%) |
| Dec 2018 | -$478.94 M(+5.8%) | -$478.94 M(+2.0%) |
| Sept 2018 | - | -$469.68 M(+1.9%) |
| June 2018 | - | -$460.92 M(+1.3%) |
| Mar 2018 | - | -$455.06 M(+0.5%) |
| Dec 2017 | -$452.70 M(+2.4%) | -$452.70 M(+1.1%) |
| Sept 2017 | - | -$447.65 M(+0.4%) |
| June 2017 | - | -$446.04 M(+0.5%) |
| Mar 2017 | - | -$443.63 M(+0.4%) |
| Dec 2016 | -$441.93 M(+2.2%) | -$441.93 M(+0.6%) |
| Sept 2016 | - | -$439.26 M(+0.4%) |
| June 2016 | - | -$437.56 M(+0.8%) |
| Mar 2016 | - | -$434.27 M(+0.4%) |
| Dec 2015 | -$432.48 M(+1.7%) | -$432.48 M(+0.4%) |
| Sept 2015 | - | -$430.78 M(+0.4%) |
| June 2015 | - | -$429.17 M(+0.5%) |
| Mar 2015 | - | -$427.08 M(+0.4%) |
| Dec 2014 | -$425.27 M(+6.6%) | -$425.27 M(+0.4%) |
| Sept 2014 | - | -$423.68 M(+5.4%) |
| June 2014 | - | -$402.14 M(+0.4%) |
| Mar 2014 | - | -$400.52 M(+0.4%) |
| Dec 2013 | -$399.07 M(+1.5%) | -$399.07 M(+0.3%) |
| Sept 2013 | - | -$397.76 M(+0.4%) |
| June 2013 | - | -$396.32 M(+0.5%) |
| Mar 2013 | - | -$394.47 M(+0.3%) |
| Dec 2012 | -$393.33 M(+3.8%) | -$393.33 M(+0.1%) |
| Sept 2012 | - | -$392.97 M(+0.3%) |
| June 2012 | - | -$391.78 M(+2.7%) |
| Mar 2012 | - | -$381.32 M(+0.7%) |
| Dec 2011 | -$378.79 M(+1.2%) | -$378.79 M(-0.3%) |
| Sept 2011 | - | -$379.79 M(+0.3%) |
| June 2011 | - | -$378.48 M(+0.4%) |
| Mar 2011 | - | -$376.82 M(+0.7%) |
| Dec 2010 | -$374.23 M | -$374.23 M(-0.3%) |
| Sept 2010 | - | -$375.29 M(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | -$373.20 M(+1.3%) |
| Mar 2010 | - | -$368.25 M(+0.6%) |
| Dec 2009 | -$366.13 M(+2.3%) | -$366.13 M(+0.5%) |
| Sept 2009 | - | -$364.39 M(-0.0%) |
| June 2009 | - | -$364.48 M(+0.8%) |
| Mar 2009 | - | -$361.43 M(+1.0%) |
| Dec 2008 | -$357.91 M(+7.1%) | -$357.91 M(+0.7%) |
| Sept 2008 | - | -$355.36 M(+1.0%) |
| June 2008 | - | -$351.96 M(+2.8%) |
| Mar 2008 | - | -$342.39 M(+2.5%) |
| Dec 2007 | -$334.05 M(+7.2%) | -$334.05 M(+1.1%) |
| Sept 2007 | - | -$330.28 M(+0.9%) |
| June 2007 | - | -$327.25 M(+2.5%) |
| Mar 2007 | - | -$319.31 M(+2.5%) |
| Dec 2006 | -$311.64 M(+19.1%) | -$311.64 M(+1.8%) |
| Sept 2006 | - | -$306.01 M(+1.2%) |
| June 2006 | - | -$302.48 M(+2.0%) |
| Mar 2006 | - | -$296.46 M(+13.3%) |
| Dec 2005 | -$261.75 M(+6.6%) | -$261.75 M(+0.8%) |
| Sept 2005 | - | -$259.57 M(+1.7%) |
| June 2005 | - | -$255.19 M(+1.7%) |
| Mar 2005 | - | -$250.89 M(+2.2%) |
| Dec 2004 | -$245.43 M(+5.4%) | -$245.43 M(+0.1%) |
| Sept 2004 | - | -$245.17 M(+1.3%) |
| June 2004 | - | -$242.03 M(+1.8%) |
| Mar 2004 | - | -$237.78 M(+2.1%) |
| Dec 2003 | -$232.81 M(+9.1%) | -$232.81 M(+2.6%) |
| Sept 2003 | - | -$226.87 M(+2.1%) |
| June 2003 | - | -$222.27 M(+2.4%) |
| Mar 2003 | - | -$217.01 M(+1.7%) |
| Dec 2002 | -$213.32 M(+22.4%) | -$213.32 M(+0.7%) |
| Sept 2002 | - | -$211.81 M(+5.9%) |
| June 2002 | - | -$200.06 M(+6.0%) |
| Mar 2002 | - | -$188.81 M(+8.3%) |
| Dec 2001 | -$174.30 M(+33.1%) | -$174.30 M(+16.0%) |
| Sept 2001 | - | -$150.29 M(-3.9%) |
| June 2001 | - | -$156.46 M(+10.5%) |
| Mar 2001 | - | -$141.58 M(+8.1%) |
| Dec 2000 | -$130.99 M(+59.4%) | -$130.99 M(+11.7%) |
| Sept 2000 | - | -$117.25 M(+10.6%) |
| June 2000 | - | -$105.97 M(+14.1%) |
| Mar 2000 | - | -$92.83 M(+12.9%) |
| Dec 1999 | -$82.19 M(+81.4%) | -$82.19 M(+21.9%) |
| Sept 1999 | - | -$67.40 M(+11.4%) |
| June 1999 | - | -$60.50 M(+15.2%) |
| Mar 1999 | - | -$52.50 M(+15.9%) |
| Dec 1998 | -$45.30 M(+42.5%) | -$45.30 M(+11.3%) |
| Sept 1998 | - | -$40.70 M(+10.9%) |
| June 1998 | - | -$36.70 M(+5.2%) |
| Mar 1998 | - | -$34.90 M(+9.7%) |
| Dec 1997 | -$31.80 M(+25.7%) | -$31.80 M(+7.1%) |
| Sept 1997 | - | -$29.70 M(+6.5%) |
| June 1997 | - | -$27.90 M(+4.5%) |
| Mar 1997 | - | -$26.70 M(+5.5%) |
| Dec 1996 | -$25.30 M | -$25.30 M(+5.4%) |
| Sept 1996 | - | -$24.00 M(+6.2%) |
| June 1996 | - | -$22.60 M(+1.8%) |
| Mar 1996 | - | -$22.20 M |
FAQ
- What is CASI Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly retained earnings year-on-year change?
What is CASI Pharmaceuticals annual retained earnings?
The current annual retained earnings of CASI is -$660.82 M
What is the all time high annual retained earnings for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual retained earnings is -$25.30 M
What is CASI Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CASI is -$685.71 M
What is the all time high quarterly retained earnings for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly retained earnings is -$22.20 M
What is CASI Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CASI quarterly retained earnings has changed by -$24.89 M (-3.77%)